Alimera Sciences, Inc.
USD5.54
-0.01 (-0.18%)
CEO
Richard S. Eiswirth Jr.
IPO Date
2019-11-04
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$5.55
Prev. Close
$5.55
Day Low
$5.53
Day High
$5.56
52W Low
$2.61
52W High
$5.65
Market Cap
$0.30B
Volume
2.68M
| 800,000 |
| $2.10 |
| 18 Sept 2024 | Caligan Partners LP | 10 percent owner | J-Other | Disposed | 1 | $0.00 |
| 18 Sept 2024 | Snisarenko John | director | D-Return | Disposed | 10,000 | $5.50 |
| 18 Sept 2024 | Snisarenko John | director | D-Return | Disposed | 50,000 | $2.99 |
| 18 Sept 2024 | Snisarenko John | director | D-Return | Disposed | 6,000 | $2.72 |
| 18 Sept 2024 | Snisarenko John | director | D-Return | Disposed | 6,000 | $4.05 |
| 18 Sept 2024 | Snisarenko John | director | D-Return | Disposed | 3,333 | $6.70 |
| 18 Sept 2024 | Snisarenko John | director | D-Return | Disposed | 46,150 | $0.86 |
| 18 Sept 2024 | Wood Todd Michael | President of U.S. Operations | D-Return | Disposed | 125,000 | $0.00 |